CDC India HIV TB Grant Eligibility
Updated 5 official sources
Quick Answer: CDC India HIV TB grant eligibility is broad on the public listing, but the practical fit is narrow.
Full answer and how we checked it
CDC-RFA-JG-26-0142 was posted August 17, 2026 and closed September 16, 2026, with about $6,000,000 in approximate year-1 funding and 2 expected awards for teams that can support India HIV and TB systems with credible country partners. Teams that missed it should use the 7 checks below to plan a subaward role with the recipients or a future cycle.
Who this is for: Public-health nonprofits, universities, health systems, data partners, and India-based or India-connected delivery teams deciding whether to lead, co-lead, subpartner, or skip this CDC global health path.
Data note: This guide uses the Simpler.Grants.gov listing for CDC-RFA-JG-26-0142 (rechecked October 9, 2026), CDC's India HIV and TB overview, CDC grants eligibility guidance, and USAspending.gov award data.
Source review by Grantsights, October 9, 2026: We rechecked the posted CDC-RFA-JG-26-0142 listing and NOFO, CDC India HIV and TB materials, CDC Global HIV and TB site materials, PEPFAR context, NACO and NTEP alignment signals, CDC grants guidance. Where official sources stop: This is a narrow India HIV and TB cooperative-agreement path, not a generic global health grant, and the practical screen is country-system access plus data and service-delivery capacity.
In this guide
- Source Check
- CDC India HIV TB Grant Eligibility: 5 Fit Tests
- 5 Funding, Timing, and Source Signals
- 4 CDC India Route Choices
- What CDC Doesn't Tell You
- 5 Real-World CDC India Scenarios
- Draft Checks to Run First
- 7 Lead-or-Partner Questions Before Writing
- 6 Reviewer-Risk Signals to Fix Before Submission
- 5 Applicant Types and Best Next Move
- 7 CDC India Route Checks Updated June 2, 2026
- Sources
Quick Facts
- Agency
- HHS
- Funding
- $0K - $0K
- Last deadline
- Sep 16, 2026 (passed)
- Status
- Closed
Assistance Listing 93.067: all awards
Source: USASpending.gov FY2024These figures cover all Centers for Disease Control-GHC awards under Assistance Listing 93.067, of every award type. They are not figures for the award this guide describes, and one award of that kind can be far smaller.
- Total Awards (FY2024, whole listing)
- 431
- Avg Award (whole listing)
- $25,317,898
- Median Award (whole listing)
- $11,671,480
- Total Funding (FY2024, whole listing)
- $1.7B
- YoY Funding Trend
- +3.1%
Data last verified: May 18, 2026
Find the foundations most likely to fund your organization
Type your organization's name. We'll show the foundations that fund groups like yours, from their own IRS filings, with the reasons for each. Free, no sign-up. See a sample
Foundations that fund this work
44,507 private foundations gave to hospitals, clinics, hospices and health charities
From their own IRS Form 990-PF filings (tax years 2019 to 2025). Pick your state to see who takes requests there, with three in full. About the list
Across the US, these foundations gave 296,132 grants totaling $49,431,675,215.
One payment
Health funder list
$29once
All 44,507 foundations, state by state.
- Each grant's amount, recipient, year and purpose
- Whether its filing says it takes requests
- How to apply, and a CSV download
Need every cause, with weekly filing alerts? Grantsights Pro is $199 a year, and a list you buy now counts toward it.
Foundation data from the foundations' own public tax returns (IRS Form 990-PF), not government grants. We never promise funding.
Other ways to buy
- Paid by card through Stripe, with an emailed receipt (refund details in our terms).
- For comparison, full foundation databases are subscriptions: Candid Premium is $1,199 a year (nonprofit price, billed annually) and Instrumentl starts at $299 a month (billed annually). This list is $29, once.
- Questions before you buy? Email Erik Jia, who runs Grantsights, at team@grantsights.com.
Grant finder
Open grants and foundations that take requests for health care.
See the best fits for your organization, free for 14 days.
Start freeNo card. Nothing is charged when it ends.
This CDC opportunity is not a generic international health grant. The opportunity is tied to India HIV and TB systems, including work with national health partners and the service, lab, surveillance, and data structures that support epidemic-control work.
Use this guide with the live CDC India HIV and TB program record, then compare broader HIV funding options in HIV AIDS grants, Ryan White HIV grants, Ryan White program guide, and federal grants complete guide. Domestic HIV programs are the wrong comparison if the work is India country-systems delivery. To compare live federal records, use the Grantsights grant database.
Source Check
Checked October 2026.
The forecast stage is over. Grantsights checked the listing again on October 9, 2026. According to the Simpler.Grants.gov listing (opens in a new tab), the NOFO (version 1, file cdc-rfa-jg-26-0142_v6_for_posting.pdf) was posted August 17, 2026, applications closed September 16, 2026, and the listing archives October 16, 2026. It names 2 expected awards, no cost sharing, and an approximate total of $6,000,000 for year 1, subject to the availability of funds. Teams that didn't apply can still position as partners or subrecipients to the eventual recipients, or prepare for a future CDC India cycle. Use the 4 checks below for either path.
The CDC country page confirms why this is not a generic HIV or TB grant. CDC says its India work includes NACO HIV work, NTEP TB collaboration, surveillance, SOCH data systems, laboratory networks, viral load coverage, treatment adherence, and TB preventive treatment for people living with HIV. Those facts are the route screen.
| Source check | What to verify before writing |
|---|---|
| Listing status | Closed September 16, 2026; check Grants.gov for award announcements or a new NOFO |
| Country fit | NACO, Central Tuberculosis Division, other MoHFW departments, NACP-VI and NTEP alignment, ART, lab, surveillance, or service-system role |
| Applicant role | Lead, co-lead, technical partner, subrecipient, or skip |
| Reporting fit | Data quality, privacy, dashboard, CDC reporting, and partner ownership |
The first planning question is not "is the applicant category listed?" It is whether the team can prove India HIV and TB public-health delivery fit in a CDC cooperative agreement.
CDC India HIV TB Grant Eligibility: 5 Fit Tests
5 program fit tests should happen before a team drafts, with 12 months of delivery readiness more important than broad eligibility language. Public applicant categories can be broad, but the winning applicant has to prove India public-health access and CDC cooperative-agreement readiness.
| Fit test | Strong signal | Red flag |
|---|---|---|
| India delivery access | Active India partner, office, or project history | No country partner |
| HIV and TB focus | Testing, linkage, treatment, retention, lab, or surveillance role | General health education only |
| Government alignment | Clear tie to NACO, NTEP, or ministry partners | Parallel project with no public-system link |
| Data capacity | Dashboards, reporting, privacy, and quality controls | Anecdotal reporting |
| CDC readiness | Cooperative-agreement management is staffed | New federal systems |
The strongest applicants will not only say they understand HIV or TB. They will show how their work changes testing, treatment, retention, TB preventive therapy, lab quality, surveillance, or service handoffs inside India systems.
5 Funding, Timing, and Source Signals
2 expected awards means partner positioning matters. The public listing shows about $6,000,000 in year-1 funding, subject to funds being available. Grantsights analysis of USAspending.gov (opens in a new tab) FY2024 records found that the connected Global AIDS assistance listing (93.067) had about $1.69B in obligations across 254 recipients.
| Listing signal | Practical meaning |
|---|---|
| $6,000,000 year-1 funding | Serious country-system capacity is expected |
| 2 expected awards | Lead-team fit matters |
| Cooperative agreement | CDC involvement should be expected |
| India HIV and TB focus | Generic global health work is not enough |
| Closed September 16, 2026 | Partner or subaward roles and future cycles are the open paths |
According to CDC's India HIV and TB overview, CDC established an office in India in 2001, works with NACO on HIV, and collaborates with NTEP on TB. CDC also describes work on surveillance, laboratory networks, viral load testing, treatment adherence, and TB prevention among people living with HIV.
4 CDC India Route Choices
4 programs are easy to confuse, and only 1 is built around India HIV and TB country systems. Ryan White is U.S. HIV care. Domestic CDC prevention funds U.S. health departments and community partners. Foundation global health can support smaller or more flexible work. This CDC India route is a country-system cooperative agreement.
| Route | Better first read when... | Why |
|---|---|---|
| CDC India HIV/TB grant | India HIV and TB system work is central | Program intent matches |
| Ryan White | U.S. HIV care and treatment is the focus | Domestic HRSA program |
| Domestic CDC HIV prevention | U.S. testing, prevention, or surveillance | Geography differs |
| Foundation global health | Smaller pilot or research support is needed | Lower federal reporting load |
For domestic HIV funding, use Ryan White HIV grants. For the broader federal HIV map, use HIV AIDS grants.
What CDC Doesn't Tell You
4 hidden fit questions matter more than the public applicant list because the listing points to only 2 awards. The listing gives the opportunity identity, but it does not tell each applicant whether its India partner model is strong enough. That is the hard question.
First, CDC does not make broad eligibility equal to readiness. A U.S. organization can have strong grant staff and still be a weak lead if it lacks India delivery access.
Second, CDC does not solve the national partner question. The NOFO supports NACO, the Central Tuberculosis Division, and other Ministry of Health and Family Welfare departments, in line with NACP-VI and NTEP. The proposal should show how the team fits those systems without creating a disconnected project.
Third, CDC does not tell you whether the team should lead. A university with strong analytics may be a better data partner than prime recipient. A health delivery organization with India operations may be a better lead.
Fourth, CDC does not turn award-family size into this specific win. The connected Global AIDS family is large, but this listing still shows only 2 expected awards.
The common mistake is writing a broad global health proposal instead of a country-system proposal. That reads thin.
5 Real-World CDC India Scenarios
5 applicant scenarios show which teams should lean in, and 2 awards mean weak lead claims should be removed early. An India-based public-health organization with HIV treatment, TB referral, and lab reporting partners may be a strong lead. A U.S. nonprofit with no India partner should not lead alone.
| Scenario | Better route | Why |
|---|---|---|
| India HIV/TB delivery network | CDC India grant | Country-system fit is present |
| U.S. university with India data partner | Co-lead or subpartner | Analytics can add value |
| Domestic HIV clinic | Ryan White or domestic CDC | Geography and system differ |
| TB research team without delivery access | Research route or partner role | Service-system fit is weak |
| Global health nonprofit with NACO/NTEP history | Lead candidate | Partner access is credible |
For example, a U.S. nonprofit with PEPFAR reporting experience and a long-term India health-system partner could be credible. A small domestic clinic with no India operations should probably find a partner role or choose a domestic HIV route.
Draft Checks to Run First
7 checks should be finished in the first 2 planning days before a team treats a future CDC India cycle, or a partner role on this one, as a priority.
- Read the posted CDC-RFA-JG-26-0142 NOFO and confirm whether a new package has been posted (this one closed September 16, 2026).
- Map India partners and their roles.
- Tie the work to HIV, TB, lab, surveillance, treatment, or retention outcomes.
- Show how NACO, NTEP, or ministry partner alignment will work.
- Build a CDC reporting and data-quality plan.
- Price the year-1 model against the $6,000,000 signal.
- Decide whether the organization should lead, co-lead, subpartner, or skip.
According to CDC, its India HIV and TB work includes support for HIV sentinel surveillance, SOCH data systems, lab quality, viral load coverage, HIV treatment adherence, and TB preventive treatment. Those details should shape the application far more than broad applicant-category language.
7 Lead-or-Partner Questions Before Writing
7 questions decide whether the applicant should draft now, and they should be answered within 2 days of finding the opportunity. The first question is country access. Does the team have staff, partners, legal authority, or operating history in India? Without that, lead status is weak.
The second question is disease-program fit. Does the project directly support HIV, TB, laboratory systems, surveillance, retention, treatment, or linked services? If not, this is probably not the right CDC path.
The third question is data. CDC cooperative agreements usually require disciplined reporting. The applicant should explain data flow, quality checks, privacy, and dashboard ownership before writing the narrative.
The fourth question is national-system alignment. The proposal should not read like a standalone pilot. It should show how the work supports existing India public-health structures.
The fifth question is role clarity. A strong analytics partner may not be the right prime. A strong delivery partner may need a U.S. compliance partner. The best team may be a true consortium.
The sixth question is timing. This competition closed September 16, 2026. The team should not spend heavily on a lead application until a new package confirms deadlines, instructions, and eligibility language.
The seventh question is exit value. What system capacity remains after the award? A strong answer should name the data, workforce, lab, or service handoff improvement that continues after the project.
According to CDC's India overview, India HIV and TB work connects to NACO, NTEP, laboratory systems, ART services, and TB prevention among people living with HIV. That means the proposal should read like public-health infrastructure work, not short-term outreach.
6 Reviewer-Risk Signals to Fix Before Submission
6 risk signals should be addressed before the team drafts a full proposal, ideally within 1 pre-review meeting. Don't spend serious writing time until these are answered in plain language.
First, the India partner role has to be documented. Don't write "local partner" as a placeholder. Name the partner type, role, access point, and decision authority.
Second, the proposal should say how it improves an existing HIV or TB workflow. A project that only adds workshops will look weak if it doesn't change testing, linkage, treatment, retention, TB screening, lab quality, or surveillance.
Third, the team needs a data path. Who collects the data? Who cleans it? Who submits it? Who owns privacy risk? Strong health programs can lose credibility when the reporting plan is too vague.
Fourth, the budget should match the 2-award reality. With about $6,000,000 listed for year 1 and 2 expected awards, a tiny demonstration may look underpowered, while a sprawling plan may look unfocused.
Fifth, the team should decide whether it belongs in a lead role. It can't treat prime status as an ego choice. A U.S. university may be the right analytics partner. An India delivery organization may be the right prime.
Sixth, any future package needs to be checked before final writing. Terms can change between cycles. Don't lock the narrative until the posted instructions confirm deadlines, eligibility, attachments, and budget rules.
5 Applicant Types and Best Next Move
5 applicant types tend to ask about this opportunity, and 2 awards means several should probably avoid lead status. The right next step depends on India access, disease-program fit, and reporting capacity.
| Applicant type | Best next move | Why |
|---|---|---|
| India public-health delivery organization | Lead or co-lead | Country access and service fit may be strong |
| U.S. university with India data work | Co-lead or analytics partner | Data value is real, but delivery may sit elsewhere |
| Domestic HIV clinic | Use Ryan White or domestic CDC | U.S. service scope does not match |
| Global health nonprofit with no India partner | Build partner role first | Country access is missing |
| Lab or surveillance contractor | Technical partner | Narrow expertise can help if tied to service outcomes |
The best public answer is not "yes, broad eligibility means apply." The best answer is: apply only if the team can prove India access, HIV/TB system fit, CDC reporting readiness, and a credible role in the partner structure.
7 CDC India Route Checks Updated June 2, 2026
7 checks now separate official source facts from applicant-specific planning. First, confirm status: the NOFO closed September 16, 2026, so the realistic paths now are a partner or subaward role with the recipients or a future cycle. Second, prove the country-system role with NACO, the Central Tuberculosis Division, NTEP, MoHFW, ART, laboratory, surveillance, TB preventive treatment, or HIV service-delivery alignment. Third, decide whether the team should lead, co-lead, subpartner, or skip.
Fourth, write the data path before the narrative: what is collected, who checks it, how it is reported, and who owns the risk. Fifth, compare this route against Ryan White, domestic CDC HIV prevention, global health foundations, and other federal options so a U.S. domestic HIV team does not force the wrong route. Sixth, price the first-year plan against the $6,000,000 signal and 2-award reality. Seventh, write a one-page next-step memo: lead a future application, seek a partner role, or skip.
Rechecked on October 9, 2026 against the Simpler Grants listing (opens in a new tab), CDC India program page (opens in a new tab), CDC eligibility guidance (opens in a new tab), Grants.gov (opens in a new tab), and USASpending.gov (opens in a new tab).
| Check | October 2026 answer |
|---|---|
| Eligibility | Confirm the applicant, institution, and route rules for CDC India HIV TB grant eligibility. |
| Source status | The NOFO closed September 16, 2026 and archives October 16, 2026; watch for award news or a new NOFO. |
| Budget | About $6,000,000 approximate year-1 total, 2 expected awards, no cost sharing. |
| Evidence | Name the data, partner role, or implementation proof needed. |
| Bad fit | Stop if the project belongs in a nearby CDC or federal route. |
| Review criteria | Tie the approach to the NOFO's stated outcomes for HIV and TB epidemic control. |
| Next action | Decide whether to seek a partner role, prepare for a future cycle, ask a program contact, or redirect. |
Final public checklist
- Confirm whether grant is the right route or whether a nearby program fits better.
- Check budget, partner, match, or data-readiness constraints.
Sources
- Simpler.Grants.gov CDC-RFA-JG-26-0142 listing: simpler.grants.gov (opens in a new tab)
- CDC India HIV and TB overview: cdc.gov (opens in a new tab)
- CDC grants eligibility guidance: cdc.gov (opens in a new tab)
- Grantsights program record: CDC India HIV and TB
Largest awards active in FY2024
One row per recipient, its largest award | 431 Assistance Listing records | Avg: $25.3M
World Health Organization
Medical Access Uganda Limited
Use the visible recipient rows as free source context
This program has no reviewed paid report today.
No reviewed paid report is currently offered for this program. The visible source rows remain free.
Next steps
Where to go next
These next pages help you move from research into a specific grant choice.
Open the CDC India record
Check CDC-RFA-JG-26-0142, forecast status, NACO and NTEP fit, award count, and source links.
Compare HIV routes
Use when the team is still deciding between global, domestic, Ryan White, and CDC HIV paths.
Check Ryan White fit
Use when the searcher is actually serving U.S. HIV care clients rather than India country systems.
Federal grant context
Compare cooperative agreement setup, registrations, and routing before drafting.
Find grants that fit you
Free eligibility check: answer 9 questions and see ranked matches with deadlines and fit reasons.
Federal Program Records to Compare
Use these current program records to check eligibility, award history, deadlines, and past winners before your team commits writing time.
Frequently Asked Questions
What is CDC-RFA-JG-26-0142?
CDC-RFA-JG-26-0142 is a CDC cooperative agreement for India HIV and TB public-health systems work supporting NACO, the Central Tuberculosis Division, and other Ministry of Health and Family Welfare departments, in line with NACP-VI and NTEP. The NOFO was posted August 17, 2026 and closed September 16, 2026.
How much year-1 funding is expected?
The public listing says CDC expects about $6,000,000 in year-1 funding, subject to funds being available.
How many awards are expected?
The Simpler.Grants.gov listing shows 2 expected awards and no cost-sharing requirement.
Who is this grant best for?
It is best for organizations with India HIV, TB, laboratory, surveillance, data, or service-delivery partner capacity.
Who should skip this grant?
Skip it if the organization lacks India delivery access, public-health data capacity, or CDC cooperative-agreement readiness.
Last updated October 9, 2026. Corrected October 9, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.
Related Guides
CDC Ethiopia Faith Based HIV TB Grant Eligibility Guide
CDC withdrew its 2026 Ethiopia faith-based HIV and TB forecast (JG-26-0136). What it offered, who fit, and 5 tests to use if CDC reissues it.
CDC Public Health Grants Guide 2026
CDC obligated $4.4 billion in grants in FY2024. Learn how immunization, HIV prevention, chronic disease, PHEP, ELC, and environmental health grants work.
Grants for HIV AIDS 2026: Ryan White, HOPWA, CDC
Ryan White got $2.571B in FY2026 and HOPWA sent $476.1M to 117 grantees. Grants for HIV/AIDS programs, plus what HIV patients can get (no cash grants).
CDC Grants and Cooperative Agreements: Funding Guide 2026
Learn how CDC grants and cooperative agreements differ, how eligibility and substantial involvement work, and where to find current funding notices.
CDC National Partners Cooperative Agreement Guide
CDC National Partners guide: 48 recipients, $176M first-year funding, 5-year cycle, bad-fit signals, and better routes for local applicants.
CDC Recent Awards: FY2026 Grants by Program
CDC signed 530 new grant records worth $338.2 million in FY2026, down from $1.61 billion. See Drug-Free Communities, block grant and partner winners.